Authors: Zhao, SZ Reynolds, MW Lefkowith, J Whelton, A Arellano, FM

Citation: Sz. Zhao et al., A comparison of renal-related adverse drug reactions between rofecoxib andcelecoxib, based on the World Health Organization Uppsala Monitoring Centre safety database, CLIN THER, 23(9), 2001, pp. 1478-1491

Authors: Pincus, T Koch, GG Sokka, T Lefkowith, J Wolfe, F Jordan, JM Luta, G Callahan, LF Wang, X Schwartz, T Abramson, SB Caldwell, JR Harrell, RA Kremer, JM Lautzenheiser, RL Markenson, JA Schnitzer, TJ Weaver, A Cummins, P Wilson, A Morant, S Fort, J

Citation: T. Pincus et al., A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee, ARTH RHEUM, 44(7), 2001, pp. 1587-1598

Authors: Seibert, K Lefkowith, J Tripp, C Isakson, P Needleman, P

Citation: K. Seibert et al., COX-2 inhibitors - Is there cause for concern?, NAT MED, 5(6), 1999, pp. 621-622

Authors: Patterson, R Bello, AE Lefkowith, J

Citation: R. Patterson et al., Immunologic tolerability profile of celecoxib, CLIN THER, 21(12), 1999, pp. 2065-2079